SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-070589
Filing Date
2017-11-28
Accepted
2017-11-28 08:25:27
Documents
3
Period of Report
2017-11-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-27579_18k.htm 8-K 22308
2 EX-99.1 a17-27579_1ex99d1.htm EX-99.1 11257
3 GRAPHIC g275791mmi001.jpg GRAPHIC 5429
  Complete submission text file 0001104659-17-070589.txt   42292
Mailing Address 2530 MERIDIAN PARKWAY SUITE 300 DURHAM NC 27713
Business Address 2530 MERIDIAN PARKWAY SUITE 300 DURHAM NC 27713 919-806-4487
Dova Pharmaceuticals, Inc. (Filer) CIK: 0001685071 (see all company filings)

IRS No.: 813858961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38135 | Film No.: 171224168
SIC: 2834 Pharmaceutical Preparations